ArticleAmerican journal of ophthalmology2018

Personalized Proteomics in Proliferative Vitreoretinopathy Implicate Hematopoietic Cell Recruitment and mTOR as a Therapeutic Target.

C Nathaniel Roybal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.